PharmaDeals Ltd

PharmaDeals Ltd is a wholly owned subsidiary of IMS Health, the leading provider of information, services and technology for the global healthcare industry. Whether you require data for benchmarking, competition analysis or simply to find out what new intellectual properties are being licensed, PharmaDeals gives you access to the latest deal making information in the pharmaceutical and biotech field. The gold standard database for deals and alliances, PharmaDeals offers the ultimate benchmarking tool.

PharmaDeals Ltd also publishes a range of reports to help pharmaceutical and biotechnology company strike better deals and understand their competitive landscape.

PharmaDeals Ltd
 

List of reports from PharmaDeals Ltd

The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
3/19/2012 | published by: PharmaDeals Ltd
... Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication. Data and analysis of a recent major survey undertaken ...  |  more...
$8,005.00
The Royalty Rate Report 2011: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
6/1/2011 | published by: PharmaDeals Ltd
... brings you the most up-to-date interpretation of royalty information. It introduces methods for calculating useful fi nancial data missing from the public domain, but essential for deal makers in benchmarking and determining value in your ...  |  more...
$8,005.00
Analysis of Deal Making in Vaccines
11/1/2010 | published by: PharmaDeals Ltd
... key players from big and small companies doing in this area? How are your potential partners and competitors operating? Around what therapeutic areas are the vaccines deals being done? How does vaccines deal making compare ...  |  more...
$4,928.00
Analysis of Oncology Deals: Trends in Deal Structures and Valuations
12/1/2009 | published by: PharmaDeals Ltd
... with? What is the impact of the credit crunch in oncology deal making and are the emerging markets having any significant effect on this therapy area? Which technologies are driving the deals and why are ...  |  more...
$2,395.00
Trends in Pharmaceutical Deal Making 2009
6/26/2009 | published by: PharmaDeals Ltd
... it can be hard to pick the optimum deal type for your situation. Even the most accomplished deal maker is unlikely to have been involved in each and every type of deal. This indispensable report ...  |  more...
$2,450.00
Effective Deal Making in Drug Delivery
2/1/2009 | published by: PharmaDeals Ltd
... to such existing therapeutics is an attractive means of prolonging the commerical viability of marketed drugs. Technologies are more difficult to value than products in clinical development because the technical risks or success rates are ...  |  more...
$5,993.00
Guide to Valuation of Pharmaceutical Licensing Deals
2/1/2009 | published by: PharmaDeals Ltd
... developments and focuses on the issues of most concern to business development and licensing professionals within the large pharmaceutical, biotechnology and academic network. It fully addresses financial modelling and provides detailed valuation examples. Its content ...  |  more...
$2,450.00
 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!